Paramount Bed Holdings Co (7817) AI Stock Analysis

• Market Cap: $138.22B
• Dividend Yield: 3.83%
• Average Volume (3M): 102.26K
• Price to Earnings (P/E): 16.1
• Beta (1Y): 0.66
• Revenue Growth: 2.42%
• EPS Growth: -13.12%
• Country: JP
• Employees: 4,126
• Sector: Healthcare
• Sector Strength: 58
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 56.86
• Shares Outstanding: 57,598,694
• 10 Day Avg. Volume: 103,400
• 30 Day Avg. Volume: 102,260
• PEG Ratio: 11.76
• Price to Book (P/B): 1.07
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 25.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 80 Outperform
• Price Target: ¥2,811.00 ▲(9.80%Upside)

Paramount Bed Holdings Co's strong financial performance and solid valuation are the most significant factors contributing to its score. Technical analysis indicates positive short-term momentum but suggests caution over the longer term. The absence of earnings call data and notable corporate events limits insights into future prospects, but the company's current financial health and valuation metrics provide a compelling case for investment.

Paramount Bed Holdings Co Business Overview & Revenue Model

Company Description

Paramount Bed Holdings Co., Ltd. is a leading Japanese company specializing in the design, manufacture, and sale of hospital and nursing care beds. Established in 1947, the company operates in the healthcare sector, supplying high-quality, innovative products aimed at improving patient care and comfort. Paramount Bed Holdings is renowned for its advanced technology and ergonomic designs, which cater to hospitals, nursing homes, and home care settings.

How the Company Makes Money

Paramount Bed Holdings Co. generates revenue primarily through the sale of its healthcare products, particularly hospital and nursing care beds. The company's revenue streams include direct sales to medical institutions, contracts with healthcare facilities, and partnerships with distributors. Additionally, Paramount Bed Holdings earns income from maintenance and after-sales services for its products. Strategic collaborations and a focus on innovation in product design help the company maintain a competitive edge and drive sales growth in both domestic and international markets.

Paramount Bed Holdings Co Financial Statement Overview

Summary

Paramount Bed Holdings Co demonstrates strong financial performance with steady revenue growth and solid profitability. The balance sheet shows low leverage and high equity, indicating financial stability. While the cash flow is positive, there is some volatility in free cash flow growth.

Income Statement

Paramount Bed Holdings Co demonstrates strong financial performance with a consistent growth trajectory. The gross profit margin has improved significantly over the years, indicating efficient cost management. The net profit margin remains robust, though it shows a slight decline in the latest year. Revenue growth is steady, reflecting the company's strong market position. EBIT and EBITDA margins are healthy, suggesting strong operational efficiency.

Balance Sheet

The company showcases a strong balance sheet with a low debt-to-equity ratio, indicating conservative financial leverage. The return on equity is impressive, reflecting effective management of shareholder funds. The equity ratio is high, suggesting a solid financial foundation and stability. Overall, the balance sheet supports the company's growth and risk management strategies.

Cash Flow

Paramount Bed Holdings Co's cash flow statement reveals a positive trend in operating cash flow, which covers net income well. The free cash flow has shown growth, although it remains somewhat volatile due to fluctuating capital expenditures. Despite this, the company's cash flow position supports its operational needs and investment activities effectively.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
108.03B	108.58B	106.02B	99.01B	90.35B	87.17B
	Gross Profit
51.80B	52.56B	50.63B	47.20B	43.03B	40.44B
	EBIT
12.51B	12.98B	13.82B	13.45B	12.34B	11.58B
	EBITDA
19.19B	24.14B	25.38B	21.62B	19.95B	19.20B
	Net Income Common Stockholders
9.92B	9.08B	10.62B	9.21B	9.09B	8.61B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
41.54B	43.54B	46.75B	53.23B	54.07B	48.36B
	Total Assets
178.11B	183.03B	180.02B	172.29B	164.28B	154.36B
	Total Debt
6.87B	6.80B	5.96B	5.51B	6.13B	7.13B
	Net Debt
-25.63B	-28.14B	-27.86B	-34.31B	-33.54B	-27.93B
	Total Liabilities
42.58B	45.74B	44.01B	43.60B	42.61B	40.54B
	Stockholders Equity
135.53B	137.28B	136.01B	128.69B	121.67B	113.82B
Cash Flow		Free Cash Flow
0.00	8.09B	3.29B	5.35B	6.30B	6.56B
	Operating Cash Flow
0.00	10.45B	7.52B	9.15B	7.82B	10.28B
	Investing Cash Flow
0.00	-141.00M	-8.40B	-6.33B	-220.00M	-1.54B
	Financing Cash Flow
0.00	-8.80B	-5.97B	-3.23B	-3.37B	-3.04B

Paramount Bed Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2560.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7817, the sentiment is Positive. The current price of 2560 is above the 20-day moving average (MA) of 2517.10, above the 50-day MA of 2403.76, and above the 200-day MA of 2512.74, indicating a bullish trend. The MACD of 52.30 indicates Negative momentum. The RSI at 60.99 is Neutral, neither overbought nor oversold. The STOCH value of 64.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7817.

Paramount Bed Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	80 Outperform	$138.22B	16.08	6.55%	3.83%	2.42%	-13.12%
7716	73 Outperform	€162.92B	28.49	4.78%	2.73%	20.53%	-75.16%
3360	68 Neutral	$182.05B	12.03	10.34%	2.89%	7.49%	9.71%
8086	64 Neutral	¥205.91B	40.27	2.07%	3.17%	9.85%	-53.97%
3593	63 Neutral	¥53.69B	56.00	1.87%	2.10%	0.10%	-41.21%
Sector *	54 Neutral	$5.37B	3.26	-45.10%	3.30%	16.81%	0.02%
7702	53 Neutral	¥10.43B	117.53		3.98%	6.83%	―

Paramount Bed Holdings Co Corporate Events

Paramount Bed Holdings Proposes Amendments to Strengthen Business and Governance

Paramount Bed Holdings Co., Ltd. announced proposed amendments to its Articles of Incorporation, which will be discussed at the upcoming Annual General Meeting of Shareholders. The changes aim to support the company’s business development by expanding the business purposes to include new areas such as communication information processing equipment and medical device programs. Additionally, the company seeks to enhance its corporate governance by increasing the number of Board Members who are Audit and Supervisory Committee Members from five to seven, reflecting its commitment to transparency and sound management.

Paramount Bed Holdings Announces Amendments to Articles of Incorporation

Paramount Bed Holdings Co., Ltd. has announced partial amendments to its Articles of Incorporation, with further details to be provided in the English version of the document in the coming weeks. This move may signal strategic adjustments in the company’s governance or operational framework, potentially impacting its market positioning and stakeholder interests.

Paramount Bed Holdings Announces Increased Year-End Dividend

Paramount Bed Holdings Co., Ltd. announced a year-end dividend of 49 yen per share for the fiscal year ending March 31, 2025, reflecting a significant increase from the previous year’s 34 yen. This decision aligns with the company’s strategy to balance shareholder returns with internal reserves to strengthen its financial position and support future growth, as outlined in its Medium-term Management Plan.

Paramount Bed Holdings Announces Leadership Changes

Paramount Bed Holdings Co., Ltd. announced a change in its Representative Board Member, with Yosuke Kimura set to take over as the new Representative Board Member and Chairperson, effective June 27, 2025. This change is part of a strategic move to revitalize the company and advance its business operations. Additionally, the company has nominated new candidates for Outside Board Members who will serve as Audit and Supervisory Committee Members, pending approval at the upcoming shareholders’ meeting.

Paramount Bed Holdings Co. Revises Dividend Policy to Enhance Shareholder Returns

Paramount Bed Holdings Co., Ltd. has announced a revision in its dividend policy, increasing its dividend on equity target from 4.0% to 5.0% starting from the fiscal year ending March 2026. This change is intended to improve shareholder returns and consider capital costs and share price, with the possibility of additional flexible returns based on market conditions.

Paramount Bed Holdings Revises Medium-term Management Plan Amid Challenging Conditions

Paramount Bed Holdings Co., Ltd. has revised its medium-term management plan targets for Phase II of ‘Paramount Vision 2030’ due to a challenging business environment. The company has adjusted its sales targets across various sectors, anticipating lower operating profits and EBITDA, while still focusing on expanding its recurring revenue businesses. These changes are driven by rising costs, sluggish domestic demand, and policy trends in key overseas markets, impacting the company’s financial projections and strategic focus.

Paramount Bed Holdings Co. Reports Fiscal Year 2025 Financial Results and Announces New Dividend Policy

Paramount Bed Holdings Co. reported a slight increase in net sales for the fiscal year ended March 31, 2025, despite a decline in operating and ordinary profits. The company announced a significant increase in dividends per share, reflecting a new dividend policy aimed at enhancing shareholder returns. This move indicates a strategic focus on maintaining investor confidence amidst fluctuating profits.